2025 - Introduced
Minnesota S.F. 1947
  • Requires that in establishing and maintaining Minnesota's preferred drug list, health insurers must not disadvantage or discourage a non-opioid drug with respect to coverage of an opioid drug.
Medicaid Parity
Read Bill
2025 - Introduced
Mississippi H.B.1389
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state Medicaid program.
Medicaid Parity
Read Bill
2025 - Introduced
Montana H.B. 774
  • Prohibits Medicaid and health insurers from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, the Montana Department of Public Health and Human Services must ensure a non-opioid is not disadvantaged or discouraged as compared to coverage of an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nebraska L.B.252 
  • Prohibits Medicaid and health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nevada S.B. 377
  • Requires health insurers and Medicaid cover at least one alternative to an opioid and prohibits insurers from requiring prior authorization or other restrictive requirements for an alternative to an opioid compared to requirements established for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Introduced
New Jersey A4682
  • Prohibits health insurers, Medicaid and School Employees’ Health Benefits from denying coverage of non-opioid prescription drugs in favor of opioid prescription drugs. Further, formularies are prohibited from disincentivizing the use of non-opioids with respect to coverage or cost-sharing.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Passed
Oklahoma S.B.1344
  • Requires that the state Medicaid preferred drug list and utilization management not disadvantage a non-opioid pain medication relative to an opioid pain medication.
  • Requires the state government to seek grant opportunities relating to education and services regarding non-opioid medications.
  • Provides that the state may assist in using opioid settlement funds to support education regarding non-opioid alternatives.
Medicaid ParityEducation
Read Bill
2025 - Introduced
Oregon S.B.598
  • Requires health insurers and Medicaid establish parity for opioids and non-opioid treatments.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
South Carolina S.B. 161
  • Prohibits preferencing coverage of an opioid prescription treatment over a non-opioid treatment and requires the South Carolina Department of Public Health to create educational materials and guidelines for practitioners about non-opioid alternative treatment options.
Medicaid ParityEducation
Read Bill
2025 - Introduced
South Dakota H.B.1137
  • Ensures FDA-approved non-opioid drugs are not disadvantaged or discouraged with respect to coverage of an opioid on the state preferred drug list.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Passed
Tennessee S.B.2011/H.B.2903
  • Prevents opioids from being preferred over a non-opioid pain medication on TennCare's preferred drug list and makes a non-opioid available immediately upon FDA-approval.
  • Requires state Medicaid departments to ensure prescribers and hospitals are reimbursed for providing non-opioid medications.
  • Prohibits health insurers from denying coverage of a non-opioid prescription drug in favor of an opioid, when prescribed.
Medicaid Parity
Read House BillRead Senate Bill
2025 - Introduced
Utah S.B. 331
  • Prohibits Medicaid and health insurers from imposing more restrictive or extensive prescription drug utilization management practices for a non-opioid drug than the least restrictive or extensive practice applicable to any opioid.
  • Requires that if Utah Department of Health and Human Services funding is available, pamphlets about opiates should include information about non-opioid drug alternatives.
Medicaid ParityState Regulated Commercial Parity
Read Bill